AstraZeneca sharpens focus on main therapy areas through agreement with gastroenterology specialist Tillotts Pharma
- Details
- Category: AstraZeneca

Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches
- Details
- Category: Novartis

Novartis deepens its industry leading pipeline with acquisition of Spinifex Pharmaceuticals, Inc.
- Details
- Category: Novartis

Pfizer enters into agreement to acquire Nimenrix and Mencevax from GlaxoSmithKline
- Details
- Category: Pfizer

Novartis highlights strong innovation momentum at its second Meet Novartis Management investor day
- Details
- Category: Novartis

Roche employees unite to raise funds for children in need
- Details
- Category: Roche

Bayer to divest Diabetes Care business to Panasonic Healthcare Holdings Co., Ltd. for EUR 1,022 million
- Details
- Category: Bayer

More Pharma News ...
- Patients reporting better quality of communication by their physician show improved self-care
- Get Ready. Get Set. Get Old.
- Amgen announces collaboration with Roche on cancer immunotherapy study with investigational medicines talimogene laherparepvec and atezolizumab
- Combination of Novartis drugs Tafinlar® and Mekinist® shows significant survival benefit in patients with metastatic melanoma
- AstraZeneca and Lilly to collaborate on Immuno-oncology combination clinical trial in solid tumours
- Pfizer announces $3 million grants program to further clinical research in advanced breast cancer
- Eureka Therapeutics Inc. and Boehringer Ingelheim announce a collaboration to identify next generation antibodies for cancer treatment